cardiovascular

cardiovascular Clinical research Pharmaceuticals Rheumatoid Arthritis

Upadacitinib outperforms adalimumab regardless of CV risk

Cardiovascular disease Conferences Guidelines Systemic sclerosis

Keep the heart front of mind in systemic sclerosis

ARA Conferences Systemic sclerosis

Putting systemic sclerosis under the microscope

cardiovascular Clinical

Rare CV deaths warning on azithromycin

Cancer cardiovascular Menopause MHT Women

MHT doesn’t cause (or prevent) cancer or heart attacks

cardiovascular Gout Rheumatology

Gout raises CVD risk by 60%